Ishikawa - Cell Line (ID:50018)

HMS LINCS ID: 50018
Name: Ishikawa
Alternative Names:
LINCS ID: LCL-1497
Alternative ID: CLO_0037163
Parent Cell Line:
Reference Source: European Collection of Authenticated Cell Cultures (ECACC) 99040201
Organism: Homo sapiens
Organ: uterus
Tissue:
Cell Type: epithelial-like
Details of Cell Type:
Donor Sex: female
Donor Age:
Donor Ethnicity:
Donor Health Status:
Disease: DOID:363, uterine cancer; DOID:1380, Endometrial cancer; DOID:2871, endometrial carcinoma; DOID:2870, endometrial adenocarcinoma
Details of Disease:
Production Details:
Genetic Modification(s): none
Known Mutations:
Citation Information for Mutations:
Verification Reference Profile: STR-PCR Data (source: ECACC): Amelogenin: X CSF1PO: 11,12 D13S317: 9,12 D16S539: 9 D5S818: 10,11 D7S820: 9,10 THO1: 9,10 TPOX: 8 vWA: 14,17
Growth Properties: adherent
Recommended Culture Conditions: ECACC growth medium: MEM + 2mM Glutamine + 1% Non Essential Amino Acids (NEAA) + 5% Foetal Bovine Serum (FBS). Subculture routine: Split sub-confluent cultures (70-80%) 1:5 i.e. seeding at 2-4x10,000 cells/cm² using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37 deg C; cells tend to pile up.
Relevant Citations:
Usage Note:
Comments:
Date Publicly Available: 2012-04-25
Most Recent Update: 2016-08-24

Batch Information for HMSL50018-1:

HMS LINCS Batch ID: 50018-1
Provider: Center for Molecular Therapeutics (CMT; Massachusetts General Hospital)
Provider Catalog ID: MGH-1111
Provider Batch ID:
Source Information: Obtained by Yangzhong Tang (Harvard Medical School) from the Center for Molecular Therapeutics (CMT; Massachusetts General Hospital) (contact: Cyril Benes).
Date Received:
HMS QC Outcome:
Transient Modification(s):
Comments:
Date Publicly Available: 2012-04-25
Most Recent Update: 2015-06-29